D-1176-2017 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-1176-2017 was initiated by RemedyRepack Inc. on Aug 22, 2017 and is designated Class II. Reason for recall: Crystallization: Product is being recalled due to the manufacturer's recall due to the presence of visible particulate in vials that has been identified as crystalline ketorolac calcium salt. The recall status is terminated (terminated Jan 3, 2018). Affected quantity: 40 vials.

Recall details

Product Type
Drugs
Report Date
Oct 4, 2017
Initiation Date
Aug 22, 2017
Termination Date
Jan 3, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
40 vials

Product description

Ketorolac Trom 30 mg/mL Injection, packaged in a) 1 mL vials, NDC 61786-0741-01 (Orig: 00548-9021-00), Ref: 33631 and b) 10 x 1 mL vials per tray, NDC 61786-0741-08 (Orig: 00548-9021-00), Ref: 33632, Rx only, Packaged by: RemedyRepack Inc, Indiana, PA 15704; Mfg by: Amphastar, Rancho Cucamonga, CA 91730.

Reason for recall

Crystallization: Product is being recalled due to the manufacturer's recall due to the presence of visible particulate in vials that has been identified as crystalline ketorolac calcium salt.

Distribution pattern

Product was distributed to one consignee in Louisiana.

Code information

Lot #: a) B0158730-060816 (Mfg: XI002A6), Exp: 12/2017 ; and b) B0160669-061516 (Mfg: XI003A6), Exp 12/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1176-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1176-2017. Report a data issue: hello@regdatalab.com.